The FDA said Summit Therapeutics' lung cancer drug ivonescimab, developed in China, failed to show a statistically significant survival benefit.
FDA Doesn't Approve Summit's China-Developed Lung Cancer Drug Investor's Business Daily.
Hence then, the article about fda doesn t approve summit s china developed lung cancer drug was published today ( ) and is available on IBD ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Doesn't Approve Summit's China-Developed Lung Cancer Drug )
Also on site :
- What channel is Spain v England Nations League match on? TV coverage, live stream and kick-off time
- Lutnick under fire: How Trump’s commerce secretary cultivated Nvidia’s CEO while chip controls slipped
- Italy Aim to Protect Top Spot Against Belgium in Nations League Clash